Mark Groudine, MD, PhD, stepped back from a rich career at Fred Hutchinson Cancer Center in 2022 to become professor emeritus. During his four decades at Fred Hutch, Groudine exemplified the organization’s breadth of scientific and clinical endeavors: While contributing fundamental discoveries about the interplay between DNA packaging, DNA’s 3D organization and gene expression, he also was a professor of radiation oncology at the University of Washington. And during his tenure as director of the Basic Sciences Division, as Fred Hutch’s deputy director, and in two stints as the organizations’ acting president and director, Groudine helped guide Fred Hutch’s scientific directions and shape its culture of excellence.
